SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
VelosBio
VelosBio Inc. is a near-term clinical-stage biopharmaceutical company focused on novel cancer targets.
